Waverley Pharma Inc. announced the resignations of both Dr. Theron (Ted) Odlaug as Chief Executive Officer (CEO) and Pieter de Visser as Chief Financial Officer (CFO) and a member of the board of directors, effective December 31, 2019. Both Dr. Odlaug and Mr. de Visser are retiring from their positions to spend more time with family. Waverley Pharma announced that Haaris Uddin has been appointed to the position of CFO and that the board of directors has initiated the search process for a new CEO, with a goal of completing the process within a few weeks.

Haaris Uddin, CPA, has been the Senior Financial Analyst at Waverley Pharma since August 2019. Previously, he worked at Ernst & Young as a senior accountant in assurance services. Mr. Uddin has significant experience working with life science companies in both Canada and the United States and spent time in both Houston, Texas and San Francisco, California working with clients.